Amgen Launches Direct-To-Patient Program Offering Repatha At 60% Discount

By Maaisha Osman / October 6, 2025 at 7:03 PM

Amgen became the latest company to launch a new direct-to-patient program, announcing Monday (Oct. 6) it will make its blockbuster cholesterol drug Repatha available at nearly a 60% discount to U.S. patients in response to the Trump administration’s push to lower drug prices.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.